Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir for chronic HCV genotype 4 or 5 (Phase 2, France)
2013-003978-27Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2015
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Harvoni in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Primary endpoint: SVR12. Started Jun 2015; status: completed.
02
Drugs
Harvoni
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2013-003978-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003978-27.